共 50 条
Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer
被引:0
|作者:
Tran, Andy
[1
,2
]
Zheng, Richard
[2
,3
]
Johnston, Fabian
[3
]
He, Jin
[2
,3
]
Burns, William R.
[2
,3
]
Shubert, Christopher
[2
,3
]
Lafaro, Kelly
[2
,3
]
Burkhart, Richard A.
[2
,3
]
机构:
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Dept Surg, Div Hepatobiliary & Pancreat Surg, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA
来源:
关键词:
TERM ONCOLOGIC OUTCOMES;
LAPAROSCOPIC PANCREATICODUODENECTOMY;
DUCTAL ADENOCARCINOMA;
SOCIOECONOMIC-STATUS;
RACIAL DISPARITIES;
LONG-TERM;
SURGERY;
SURVIVAL;
STAGE;
EXPERIENCE;
D O I:
10.1016/j.hpb.2024.07.403
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Background: Minimally invasive pancreatic surgery (MIPS), when selectively utilized, has been shown to hasten recovery with outcomes comparable to open approaches, but access may not be equitable. This study explored variation in utilization of MIPS for pancreatic cancer. Methods: The National Cancer Database was queried to identify patients diagnosed with a primary pancreatic neoplasm from 2010 to 2020. Study participants had diagnoses of clinical or pathologic stage 1-3 disease and received curative-intent surgery. Multivariable analyses assessed the association between surgical approach and patient and disease factors. Results: Inclusion criteria identified 73,137 patients: 51,408 underwent open surgery and 21,729 received MIPS. In our multivariable analysis, Black race was associated with reduced odds of MIPS (AOR 0.88; p = 0.02), while older age (AOR 1.17; p = 0.01), later year of diagnosis (AOR 1.57; p < 0.001), and private insurance coverage (AOR 1.30; p = 0.05) were associated with increased odds. When patients with adenocarcinoma were analyzed in isolation, disparities in MIPS utilization persisted even when controlling for disease stage. Conclusion: Sociodemographic factors like age, race, and insurance coverage appear to vary in the utilization of MIPS technologies for the treatment of pancreatic malignancy. Addressing variation with robust mixed methods approaches in the future is proposed to incorporate prospective interventions with highly annotated outcomes for additional study.
引用
收藏
页码:1280 / 1290
页数:11
相关论文